The CDC has appointed Robyn Neblett Fanfair, MD, as the permanent director of the Division of HIV Prevention, which falls under the National Center for HIV, Viral Hepatitis, STD, and TB Prevention, according to a Feb. 12 news release.
Category: Static
Physician-led group details way to reduce burnout, ease rural care burdens
The National Board of Physicians and Surgeons, a nonprofit that provides accessible, ongoing certification in medical specialties, has released a plan aimed at reducing clinician burnout and burdens in rural care.
US healthcare workers walk off the job: 4 strikes in 2024
Last year was marked by labor actions across the U.S. From coast to coast, healthcare workers participated in strikes, citing concerns about issues such as pay, staffing and recruitment, and such actions have continued into 2024.
Sutter taps hospital CEO from Tenet
Sutter Coast Hospital in Crescent City, Calif., has named Michael Lane its new CEO.
CoxHealth rehires staff from Oracle
Ninety percent of laid-off staff from Oracle Health, who were conducting health information technology operations for Springfield, Mo.-based CoxHealth, have accepted new job offers with the health system.
50% of rural hospitals are operating in the red: 7 things to know
Half of rural hospitals are operating in the red, up seven percentage points from last year, according to a Feb. 13 report from the Chartis Center for Rural Health.
Steward concerns trickle South
Questions about Steward Health Care’s stability have spread from Massachusetts to a 278-bed hospital in Louisiana.
Why Arizona could soon have the nation's worst nursing shortage
Arizona could have the worst nursing shortage crisis in the nation by 2025 with nearly 28,100 vacancies in roles needed to maintain normal levels of care, according to data from the National Center for Health Workforce Analysis.
NewYork-Presbyterian plans new cancer center
NewYork-Presbyterian plans to build a nearly 400,000-square-foot cancer center at its Columbia University Irving Medical Center in New York City’s Washington Heights neighborhood.
FDA clears drug for metastatic pancreatic cancer
The FDA has granted approval to a new medicine for patients with aggressive, metastatic pancreatic adenocarcinoma. The agency began its priority review of the drug following positive phase 3 trial results.
